- Apr 2, 2009
- 5,171
- 13,288
- 67
FDA changes labels to encourage use of nicotine gums, lozenges and patches
Nicotine Replacement Therapy Labels May Change
It didn't take Mitch Zeller very long to reward his former employer (GlaxoSmithKline) with a regulatory change intended to increase consumption of nicotine gums, lozenges and patches.
I've been urging FDA to eliminate its mandatory and counterproductive warnings on NRT products that state:
- Do not use if you continue using tobacco. and
- Stop using after 12 weeks.
But the agency's new warning label statements falsely imply that NRT is an effective treatment for smoking cessation, and fail to warn consumers that NRT has a 95% failure rate for smoking cessation and for treating tobacco dependence (which is what FDA approves it for treating).
The new warnings also fail to inform consumers that NRT can be used as a temporary and/or long term substitute for cigarettes and other tobacco products, and that many smokeless tobacco and other new smokefree alternatives are very similar to FDA approved NRT products.
The FDA notice included a photo of a doctor in white lab coat with a patient, and the following statement.
Patients should consult with their health care professional to select the most appropriate smoking cessation method to suit their needs, and to discuss any questions about the use of OTC nicotine replacement products. FDA has not seen evidence to support the statement that these products are safe for all smokers.
Nicotine Replacement Therapy Labels May Change
It didn't take Mitch Zeller very long to reward his former employer (GlaxoSmithKline) with a regulatory change intended to increase consumption of nicotine gums, lozenges and patches.
I've been urging FDA to eliminate its mandatory and counterproductive warnings on NRT products that state:
- Do not use if you continue using tobacco. and
- Stop using after 12 weeks.
But the agency's new warning label statements falsely imply that NRT is an effective treatment for smoking cessation, and fail to warn consumers that NRT has a 95% failure rate for smoking cessation and for treating tobacco dependence (which is what FDA approves it for treating).
The new warnings also fail to inform consumers that NRT can be used as a temporary and/or long term substitute for cigarettes and other tobacco products, and that many smokeless tobacco and other new smokefree alternatives are very similar to FDA approved NRT products.
The FDA notice included a photo of a doctor in white lab coat with a patient, and the following statement.
Patients should consult with their health care professional to select the most appropriate smoking cessation method to suit their needs, and to discuss any questions about the use of OTC nicotine replacement products. FDA has not seen evidence to support the statement that these products are safe for all smokers.
Last edited: